Biosimilar Policy Subgroup - 6 April 2018 - Communique
Page last updated: 10 October 2018
The Biosimilar Policy subgroup of the Access to Medicines Working Group and Generic Medicines Working Group met on 6 April 2018. Attendees included representatives from the Generic and Biosimilar Medicines Association, Medicines Australia, industry and the Department of Health.
This was the second meeting of the Biosimilar Policy subgroup.
Members discussed Biosimilar Policy including PBS data, uptake drivers and active ingredient prescribing to support biosimilar uptake, and are working on ways to measure and publish the impact of policies supporting biosimilar uptake. The Biosimilar Policy Subgroup will continue to consider ways to support a functioning and competitive biosimilars market in Australia.
